Clinical trial Recruiting at 1 site Observational Ages 18 to 89

Examining testosterone levels and skin bacteria in shoulder surgery patients

Official title: Association Between Serum Testosterone Levels and Cutibacterium Culture Positivity During Shoulder Arthroplasty

Run by University of Washington · NCT05030220 · Data updated 2026-11-12

This study is trying to see if testosterone levels in patients having shoulder surgery are linked to certain bacteria on their skin and if this affects their risk of infection after the surgery.

More Arthroplasty, Replacement, Knee trials

Quick facts

Study typeObservational
Ages18 Years to 89 Years
SexAll
Enrollment300 (estimated)
SponsorUniversity of Washington
Academic / other
Locations1 site (Seattle, Washington)
StatusRecruiting
StartedJuly 1, 2020
Main results expectedJanuary 1, 2027
Study endsJanuary 1, 2027
Registry record updatedMarch 30, 2025
Trial IDNCT05030220 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients scheduled for elective shoulder arthroplasty who meet the inclusion criteria.

Probably not a fit

Patients with a history of shoulder septic arthritis or recent antibiotic use may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the relationship between serum testosterone levels and the presence of Cutibacterium bacteria in patients undergoing shoulder arthroplasty. In the first phase, blood samples and skin swabs are collected from 51 patients before and during surgery to analyze testosterone levels and bacterial load. The second phase aims to assess whether preoperative testosterone levels correlate with the risk of periprosthetic joint infection and bacterial load in deep tissue cultures during revision surgeries. The study seeks to enhance understanding of how testosterone may influence surgical outcomes.

Why it matters

Potential benefit: If successful, this study could help identify risk factors for infections in shoulder arthroplasty patients, potentially leading to improved surgical outcomes.

How similar studies have gone: While the specific correlation between testosterone levels and Cutibacterium in shoulder surgeries is novel, similar studies have explored testosterone's role in infection risk in other surgical contexts.

Who can join: the full rules

Show full inclusion / exclusion criteria
Phase 1 Inclusion Criteria:

* Patients having elective shoulder arthroplasty

Phase 1 Exclusion Criteria:

* history of shoulder septic arthritis
* antibiotic use within 3 months prior to surgery
* recent treatment for acne
* Lacked fluency in English

Phase 2 Inclusion Criteria:

* Patients having elective shoulder arthroplasty

Phase 2 Exclusion Criteria:

* Lacked fluency in English

Where it's running

  • University of Washington
    Seattle, Washington, United States
    Recruiting

Study contacts

  • Principal investigator: Jason E Hsu, MD — University of Washington
  • Study coordinator: Jason E Hsu, MD
  • Email: jehsu@uw.edu
  • Phone: 330-883-8829

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.